The first CRISPR therapy approved in the U.S. will treat sickle cell disease

FDA approves world's first CRISPR gene-editing drug for sickle cell disease

Historic FDA approval of the first CRISPR-Cas9 drug for Sickle Cell Disease based on discoveries from Jennifer Doudna & Emmanuelle Charpentier, CRISPR Therapeutics & Vertex Pharmaceuticals.

Their budget already stretched near bursting, U.S. particle physicists dream small